10-Q: Colgate-Palmolive Reports Q3 2024 Results: Sales and Profitability Rise Amidst Global Challenges

Sentiment:

Quarterly Report


Colgate-Palmolive's third-quarter 2024 results show a 2.4% increase in net sales and improved profitability, driven by volume growth and pricing actions, despite negative foreign exchange impacts.

Better than expectedThe company's organic sales growth of 6.8% exceeded expectations.The gross profit margin improved to 61.1%, indicating better cost management.Diluted earnings per share increased to $0.90, surpassing the previous year's result.

Summary

  • Colgate-Palmolive's net sales for the third quarter of 2024 reached $5.033 billion, a 2.4% increase compared to the same period in 2023.
  • This growth was driven by a 3.7% increase in volume and a 3.1% increase in net selling prices, partially offset by a 4.4% negative impact from foreign exchange.
  • Organic sales, which exclude the impact of foreign exchange, acquisitions, and divestments, grew by 6.8% in the third quarter of 2024.
  • Gross profit for the quarter was $3.074 billion, up from $2.877 billion in the previous year, with gross profit margin increasing to 61.1% from 58.5%.
  • Operating profit increased by 4% to $1.065 billion, and net income attributable to Colgate-Palmolive Company rose to $737 million from $708 million.
  • Diluted earnings per share increased to $0.90 from $0.86 year-over-year.
  • For the first nine months of 2024, net sales were $15.156 billion, a 4.5% increase compared to the same period in 2023, with organic sales up 8.5%.
  • The company's global toothpaste market share was 41.6% year-to-date, up 0.5 share points, and its global manual toothbrush market share was 32.3%, up 0.9 share points.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with strong sales and profitability growth, but acknowledges significant challenges and risks, resulting in a moderately positive sentiment.

Positives

  • The company experienced strong volume growth of 3.7% in Q3 2024.
  • Net selling prices increased by 3.1% in Q3 2024, contributing to revenue growth.
  • Cost savings from funding-the-growth initiatives contributed to the increase in gross profit margin.
  • Hills Pet Nutrition segment saw a 6.3% increase in net sales and a 28% increase in operating profit.
  • The company is actively managing its supply chain and implementing cost-reduction initiatives.
  • The company is investing in advertising and digital capabilities to drive growth.

Negatives

  • Foreign exchange had a negative impact of 4.4% on net sales in Q3 2024.
  • Selling, general, and administrative expenses increased by 9% in Q3 2024.
  • The North America segment experienced a 2.1% decrease in net sales.
  • The Africa/Eurasia segment saw a 1% decrease in operating profit.
  • The company is facing increased competition and evolving retail landscapes.
  • The company is experiencing volatile foreign currency fluctuations, particularly in Argentina and Trkiye.

Risks

  • The company faces challenges from global macroeconomic conditions, including inflation and high interest rates.
  • Foreign currency volatility, particularly in hyper-inflationary economies, poses a risk to financial results.
  • Increased competition and evolving competitive practices may impact market share and profitability.
  • Changes in trade customer policies, such as inventory destocking, could negatively affect sales.
  • Geopolitical events, such as the wars in Ukraine and the Middle East, create uncertainties and risks.
  • The company is subject to various legal proceedings, including tax and civil matters in Brazil and talcum powder litigation.

Future Outlook

The company expects continued volatility across all categories due to challenging macroeconomic conditions, including inflation, high interest rates, and foreign currency fluctuations. They plan to continue investing in high-growth segments, digital capabilities, and cost-reduction initiatives to drive long-term growth and shareholder value.

Management Comments

  • Management is focused on driving organic sales growth and consistent compounded earnings per share growth.
  • The company is prioritizing investments in high-growth segments within Oral Care, Personal Care, and Pet Nutrition businesses.
  • Management believes that growth opportunities are greater in areas with economic development and rising consumer incomes.
  • The company is strengthening capabilities in innovation, digital, artificial intelligence, eCommerce, and data analytics.

Industry Context

The announcement reflects the broader consumer goods industry's challenges in navigating inflation, supply chain disruptions, and evolving consumer preferences. Colgate-Palmolive's focus on cost management and strategic investments aligns with industry trends aimed at maintaining profitability and market share in a competitive environment.

Comparison to Industry Standards

  • Colgate-Palmolive's organic sales growth of 6.8% in Q3 2024 is a strong result compared to some of its peers in the consumer goods sector, such as Procter & Gamble, which reported a 3% organic sales growth in their most recent quarter.
  • The company's gross profit margin of 61.1% is also competitive, although some premium brands in the personal care space may have higher margins.
  • Unilever, another major player in the consumer goods industry, has been focusing on similar strategies of cost-cutting and strategic brand investments, indicating a common approach to navigating current market conditions.
  • The company's market share gains in toothpaste and manual toothbrushes demonstrate its ability to maintain a competitive edge against rivals like GlaxoSmithKline and smaller regional players.
  • Compared to other pet food companies, such as Nestle Purina, Hill's Pet Nutrition's 6.5% organic sales growth is solid, reflecting the continued strength of the pet care market.

Legal Proceedings

  • The company is involved in tax and civil proceedings in Brazil related to the 1995 acquisition of the Kolynos oral care business.
  • The company is a defendant in civil actions alleging that certain of its talcum powder products were contaminated with asbestos.
  • The company is appealing a decision related to a lawsuit under the Employee Retirement Income Security Act (ERISA).

Stakeholder Impact

  • Shareholders will benefit from increased earnings per share and potential long-term growth.
  • Employees may be affected by restructuring and cost-reduction initiatives.
  • Customers may experience changes in product availability and pricing due to supply chain and economic factors.
  • Suppliers may be impacted by changes in sourcing strategies and cost-reduction efforts.

Next Steps

  • The company will continue to implement its 2022 Global Productivity Initiative.
  • The company will continue to invest in high-growth segments and digital capabilities.
  • The company will continue to monitor and manage the impact of geopolitical events and economic conditions.
  • The company will continue to focus on cost-reduction and efficiency initiatives.

Key Dates

DateDescription
January 27, 2022The Board of Directors approved the 2022 Global Productivity Initiative.
September 13, 2023The Committee adopted the Guidelines Regarding the Effect of Termination of Employment on Awards under the Plan.
July 1, 2024The company realigned the reporting structure of its skin health business.
September 30, 2024End of the third quarter of 2024.
October 25, 2024Date of the filing of the Quarterly Report on Form 10-Q.

Keywords

Colgate-Palmolive, Q3 2024, Financial Results, Net Sales, Organic Sales, Gross Profit, Operating Profit, Earnings Per Share, Market Share, Pet Nutrition, Oral Care, Personal Care, Home Care, Restructuring, Cost Savings, Global Productivity Initiative

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.